StonvexLoading…
StonvexCore line items from PAYX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Annual 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $4.75B | $3.00B | $1.49B | $5.41B |
Operating Income | $1.91B | $1.11B | $541.90M | $2.21B |
Net Income | $1.34B | $779.20M | $383.80M | $1.66B |
EPS (Diluted) | $3.71 | $2.16 | $1.06 | $4.58 |
Total Assets | $17.51B | $16.52B | $16.66B | $16.56B |
Total Liabilities | $13.50B | $12.64B | $12.69B | $12.44B |
Cash & Equivalents | $1.74B | $1.49B | $809.00M | $1.63B |
Free Cash Flow OCF − CapEx | $1.81B | $1.05B | $662.50M | $1.71B |
Shares Outstanding | 358.30M | 359.00M | 359.90M | 360.50M |